NeoAdjuvant Pembrolizumab and STEreotactic Radiotherapy Prior to Nephrectomy for Renal Cell Carcinoma

NCT05024318 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Renal Cell Carcinoma, Clear Cell, Somatic

Interventions

DRUG: Pembrolizumab
RADIATION: Stereotactic Ablative Radiotherapy
PROCEDURE: Nephrectomy

Sponsor

Peter MacCallum Cancer Centre, Australia